Piper Sandler analyst Matt O’Brien downgraded Teleflex (TFX) to Neutral from Overweight with a price target of $140, down from $255. The ...

Teleflex Incorporated TFX posted fourth-quarter 2024 adjusted earnings per share (EPS) from continuing operations of $3.89, ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Teleflex Incorporated (NYSE: TFX) has announced its agreement to acquire BIOTRONIK’s Vascular Intervention business in a ...

Teleflex to create a new, independent publicly traded company consisting of its Urology, Acute Care, and OEM businesses.